Stock Revamps on Eco Changes: Endo International (NASDAQ:ENDP), Synchronoss Technologies (NASDAQ:SNCR)
Endo International plc (NASDAQ:ENDP) [Trend Analysis] knocking active thrust in leading trading session, shares a decrease of -0.06% to 15.86 with around 4.3 Million shares have changed hands in this session. Endo International plc (ENDP) released that its operating company, Par Pharma, has begun shipping mycophenolatemofetil hydrochloride for injection, which is the generic version of Roche’s CellCept. Mycophenolatemofetil hydrochloride for injection is packaged in cartons of four 500 mg single dose vials.Endo International noted that, according to IMS Health data, U.S. sales of injectabl...
Source: streetwisereport.com